| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 9, 725-733, Copyright © 1995 by Endocrine Society
ARTICLES |
J Parma, J Van Sande, S Swillens, M Tonacchera, J Dumont and G Vassart
Institut de Recherche Interdisciplinaire, Faculty of Medicine, University of Brussels, Belgium.
A series of somatic mutations of the TSH receptor gene have been demonstrated in hyperfunctioning thyroid adenomas. The mutations studied up to now cause constitutive (i.e. TSH-independent) activation of the cAMP-regulatory cascade only. As a follow-up to our original study, we have now completely sequenced exon number 10 of the TSH receptor gene in the same series of toxic adenomas. An activating mutation was found in nine of 11 tumors. In addition to the mutations already described, two isoleucine residues belonging to the first and second extracellular loops of the receptor (Ile486 and Ile568) were found mutated. Two different adenomas were found to harbor a different amino acid substitution at residue 486 (Ile486Phe, Ile486Met). Ile568 was mutated to threonine in one. When studied by transfection in COS-7 cells, all three mutations caused very strong activation of the cAMP- regulatory cascade. In addition, the Ile486Phe and, to a lesser extent, the Ile486Met and Ile568Thr mutants stimulated constitutively the inositol phosphate-diacylglycerol cascade. Our results demonstrate that 1) the first and second extracellular loops contribute to the silencing of the unliganded TSH receptor; 2) the two regulatory cascades normally under TSH control can be constitutively activated by somatic mutations of the receptor; 3) the TSH receptor can be activated by mutation of a large number of residues distributed over the first and second extracellular loops, the third intracellular loop, and the third, sixth, and seventh transmembrane segments; 4) activating mutations of the TSH receptor constitute the major cause of toxic adenomas, accounting for about 80% of the cases.
This article has been cited by other articles:
![]() |
G. Kleinau and G. Krause Thyrotropin and Homologous Glycoprotein Hormone Receptors: Structural and Functional Aspects of Extracellular Signaling Mechanisms Endocr. Rev., April 1, 2009; 30(2): 133 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sura-Trueba, C. Aumas, A. Carre, S. Durif, J. Leger, M. Polak, and N. de Roux An Inactivating Mutation within the First Extracellular Loop of the Thyrotropin Receptor Impedes Normal Posttranslational Maturation of the Extracellular Domain Endocrinology, February 1, 2009; 150(2): 1043 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Palos-Paz, O Perez-Guerra, J Cameselle-Teijeiro, C Rueda-Chimeno, F Barreiro-Morandeira, J Lado-Abeal, the Galician Group for the Study of Toxic Multinod, D Araujo Vilar, R Argueso, O Barca, et al. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain Eur. J. Endocrinol., November 1, 2008; 159(5): 623 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Benned-Jensen and M. M. Rosenkilde Structural Motifs of Importance for the Constitutive Activity of the Orphan 7TM Receptor EBI2: Analysis of Receptor Activation in the Absence of an Agonist Mol. Pharmacol., October 1, 2008; 74(4): 1008 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kleinau, H. Jaeschke, S. Mueller, B. M. Raaka, S. Neumann, R. Paschke, and G. Krause Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor FASEB J, August 1, 2008; 22(8): 2798 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. G. Pfleger, A. J. Pawson, and R. P. Millar Changes to Gonadotropin-Releasing Hormone (GnRH) Receptor Extracellular Loops Differentially Affect GnRH Analog Binding and Activation: Evidence for Distinct Ligand-Stabilized Receptor Conformations Endocrinology, June 1, 2008; 149(6): 3118 - 3129. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mizutori, C.-R. Chen, S. M. McLachlan, and B. Rapoport The Thyrotropin Receptor Hinge Region Is Not Simply a Scaffold for the Leucine-Rich Domain but Contributes to Ligand Binding and Signal Transduction Mol. Endocrinol., May 1, 2008; 22(5): 1171 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Moreno-Reyes, B.-N.-T. Tang, A. Seret, S. Goldman, C. Daumerie, and B. Corvilain Impaired Iodide Organification in Autonomous Thyroid Nodules J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4719 - 4724. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-R. Chen, S. M. McLachlan, and B. Rapoport Suppression of Thyrotropin Receptor Constitutive Activity by a Monoclonal Antibody with Inverse Agonist Activity Endocrinology, May 1, 2007; 148(5): 2375 - 2382. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Ho, S.-S. Goh, I. H C Kee, P. K H Chow, C.-P. Yeo, and D. H C Khoo Effects of genetic immunization of Swiss outbred mice with human thyroid stimulating hormone receptor cDNA plasmids harboring gain-of-function mutations J. Mol. Endocrinol., February 1, 2007; 38(2): 277 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kleinau, M. Brehm, U. Wiedemann, D. Labudde, U. Leser, and G. Krause Implications for Molecular Mechanisms of Glycoprotein Hormone Receptors Using a New Sequence-Structure-Function Analysis Resource Mol. Endocrinol., February 1, 2007; 21(2): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kleinau, M. Claus, H. Jaeschke, S. Mueller, S. Neumann, R. Paschke, and G. Krause Contacts between Extracellular Loop Two and Transmembrane Helix Six Determine Basal Activity of the Thyroid-stimulating Hormone Receptor J. Biol. Chem., January 5, 2007; 282(1): 518 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mueller, G. Kleinau, H. Jaeschke, S. Neumann, G. Krause, and R. Paschke Significance of Ectodomain Cysteine Boxes 2 and 3 for the Activation Mechanism of the Thyroid-stimulating Hormone Receptor J. Biol. Chem., October 20, 2006; 281(42): 31638 - 31646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Rosenkilde, T. Benned-Jensen, H. Andersen, P. J. Holst, T. N. Kledal, H. R. Luttichau, J. K. Larsen, J. P. Christensen, and T. W. Schwartz Molecular Pharmacological Phenotyping of EBI2: AN ORPHAN SEVEN-TRANSMEMBRANE RECEPTOR WITH CONSTITUTIVE ACTIVITY J. Biol. Chem., May 12, 2006; 281(19): 13199 - 13208. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jaeschke, S. Neumann, G. Kleinau, S. Mueller, M. Claus, G. Krause, and R. Paschke An Aromatic Environment in the Vicinity of Serine 281 Is a Structural Requirement for Thyrotropin Receptor Function Endocrinology, April 1, 2006; 147(4): 1753 - 1760. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Claus, H. Jaeschke, G. Kleinau, S. Neumann, G. Krause, and R. Paschke A Hydrophobic Cluster in the Center of the Third Extracellular Loop Is Important for Thyrotropin Receptor Signaling Endocrinology, December 1, 2005; 146(12): 5197 - 5203. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Karges, G. Krause, J. Homoki, K.-M. Debatin, N. de Roux, and W. Karges TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5 J. Endocrinol., August 1, 2005; 186(2): 377 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Neumann, M. Claus, and R. Paschke Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation Eur. J. Endocrinol., April 1, 2005; 152(4): 625 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Al-Khafaji, M Wiltshire, D Fuhrer, G Mazziotti, M D Lewis, P J Smith, and M Ludgate Biological activity of activating thyrotrophin receptor mutants: modulation by iodide J. Mol. Endocrinol., February 1, 2005; 34(1): 209 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Singh, D. McDonald, T. J. Hope, and B. S. Prabhakar Upon Thyrotropin Binding the Thyrotropin Receptor Is Internalized and Localized to Endosome Endocrinology, February 1, 2004; 145(2): 1003 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-R. Chen, G. D. Chazenbalk, S. M. McLachlan, and B. Rapoport Evidence that the C Terminus of the A Subunit Suppresses Thyrotropin Receptor Constitutive Activity Endocrinology, September 1, 2003; 144(9): 3821 - 3827. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fuhrer, M. D. Lewis, F. Alkhafaji, K. Starkey, R. Paschke, D. Wynford-Thomas, M. Eggo, and M. Ludgate Biological Activity of Activating Thyroid-Stimulating Hormone Receptor Mutants Depends on the Cellular Context Endocrinology, September 1, 2003; 144(9): 4018 - 4030. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Levin, S. Marullo, O. Muntaner, B. Andersson, and Y. Magnusson The Myocardium-protective Gly-49 Variant of the beta 1-Adrenergic Receptor Exhibits Constitutive Activity and Increased Desensitization and Down-regulation J. Biol. Chem., August 16, 2002; 277(34): 30429 - 30435. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Alberti, M. C. Proverbio, S. Costagliola, R. Romoli, B. Boldrighini, M. C. Vigone, G. Weber, G. Chiumello, P. Beck-Peccoz, and L. Persani Germline Mutations of TSH Receptor Gene as Cause of Nonautoimmune Subclinical Hypothyroidism J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2549 - 2555. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Ford, A. Essex, T. A. Spalding, E. S. Burstein, and J. Ellis Homologous Mutations Near the Junction of the Sixth Transmembrane Domain and the Third Extracellular Loop Lead to Constitutive Activity and Enhanced Agonist Affinity at all Muscarinic Receptor Subtypes J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 810 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Lee, T. J. Kotlar, I. Ciric, M. K. Lee, S. K. Lim, H. C. Lee, K. B. Huh, K. E. Mayo, and J. L. Jameson Absence of Constitutively Activating Mutations in the GHRH Receptor in GH-Producing Pituitary Tumors J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3989 - 3995. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Ho, J. Van Sande, A. Lefort, G. Vassart, and S. Costagliola Effects of Mutations Involving the Highly Conserved S281HCC Motif in the Extracellular Domain of the Thyrotropin (TSH) Receptor on TSH Binding and Constitutive Activity Endocrinology, July 1, 2001; 142(7): 2760 - 2767. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Shirokawa, R. Elisei, J. A. Knauf, T. Hara, J. Wang, H. I. Saavedra, and J. A. Fagin Conditional Apoptosis Induced by Oncogenic Ras in Thyroid Cells Mol. Endocrinol., November 1, 2000; 14(11): 1725 - 1738. [Abstract] [Full Text] |
||||
![]() |
M. Tonacchera, P. Agretti, L. Chiovato, V. Rosellini, G. Ceccarini, A. Perri, P. Viacava, A. G. Naccarato, P. Miccoli, A. Pinchera, et al. Activating Thyrotropin Receptor Mutations Are Present in Nonadenomatous Hyperfunctioning Nodules of Toxic or Autonomous Multinodular Goiter J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2270 - 2274. [Abstract] [Full Text] |
||||
![]() |
A. Lienhardt, M. Garabédian, M. Bai, C. Sinding, Z. Zhang, J.-P. Lagarde, J. Boulesteix, M. Rigaud, E. M. Brown, and M.-L. Kottler A Large Homozygous or Heterozygous In-Frame Deletion within the Calcium-Sensing Receptor's Carboxylterminal Cytoplasmic Tail That Causes Autosomal Dominant Hypocalcemia J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1695 - 1702. [Abstract] [Full Text] |
||||
![]() |
M. Tonacchera, P. Agretti, A. Pinchera, V. Rosellini, A. Perri, P. Collecchi, P. Vitti, and L. Chiovato Congenital Hypothyroidism with Impaired Thyroid Response to Thyrotropin (TSH) and Absent Circulating Thyroglobulin: Evidence for a New Inactivating Mutation of the TSH Receptor Gene J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1001 - 1008. [Abstract] [Full Text] |
||||
![]() |
U. Gether Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors Endocr. Rev., February 1, 2000; 21(1): 90 - 113. [Abstract] [Full Text] |
||||
![]() |
M. Tonacchera, P. Vitti, P. Agretti, G. Ceccarini, A. Perri, R. Cavaliere, B. Mazzi, A. G. Naccarato, P. Viacava, P. Miccoli, et al. Functioning and Nonfunctioning Thyroid Adenomas Involve Different Molecular Pathogenetic Mechanisms J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4155 - 4158. [Abstract] [Full Text] |
||||
![]() |
C. Baratti-Elbaz, N. Ghinea, O. Lahuna, H. Loosfelt, C. Pichon, and E. Milgrom Internalization and Recycling Pathways of the Thyrotropin Receptor Mol. Endocrinol., October 1, 1999; 13(10): 1751 - 1765. [Abstract] [Full Text] |
||||
![]() |
G. D. Chazenbalk, K. Tanaka, S. M. McLachlan, and B. Rapoport On the Functional Importance of Thyrotropin Receptor Intramolecular Cleavage Endocrinology, October 1, 1999; 140(10): 4516 - 4520. [Abstract] [Full Text] |
||||
![]() |
E. Schipani, C. Langman, J. Hunzelman, M. Le Merrer, K. Y. Loke, M. J. Dillon, C. Silve, and H. Jüppner A Novel Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Mutation in Jansen's Metaphyseal Chondrodysplasia J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3052 - 3057. [Abstract] [Full Text] |
||||
![]() |
E. M. Gabriel, E. R. Bergert, C. S. Grant, J. A. van Heerden, G. B. Thompson, and J. C. Morris Germline Polymorphism of Codon 727 of Human Thyroid-Stimulating Hormone Receptor Is Associated with Toxic Multinodular Goiter J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3328 - 3335. [Abstract] [Full Text] |
||||
![]() |
K. Befort, C. Zilliox, D. Filliol, S. Yue, and B. L. Kieffer Constitutive Activation of the delta Opioid Receptor by Mutations in Transmembrane Domains III and VII J. Biol. Chem., June 25, 1999; 274(26): 18574 - 18581. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Le Gouill, J.-L. Parent, C.-A. Caron, R. Gaudreau, L. Volkov, M. Rola-Pleszczynski, and J. Stankova Selective Modulation of Wild Type Receptor Functions by Mutants of G-Protein-coupled Receptors J. Biol. Chem., April 30, 1999; 274(18): 12548 - 12554. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kremer, J. W. M. Martens, M. van Reen, M. Verhoef-Post, J. M. Wit, B. J. Otten, S. L. S. Drop, H. A. Delemarre-van de Waal, M. Pombo-Arias, F. De Luca, et al. A Limited Repertoire of Mutations of the Luteinizing Hormone (LH) Receptor Gene in Familial and Sporadic Patients with Male LH-Independent Precocious Puberty J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1136 - 1140. [Abstract] [Full Text] |
||||
![]() |
B. Rapoport, G. D. Chazenbalk, J. C. Jaume, and S. M. McLachlan The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies Endocr. Rev., December 1, 1998; 19(6): 673 - 716. [Abstract] [Full Text] |
||||
![]() |
H. Biebermann, T. Schöneberg, A. Schulz, G. Krause, A. Grüters, G. Schultz, and T. Gudermann A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling FASEB J, November 1, 1998; 12(14): 1461 - 1471. [Abstract] [Full Text] |
||||
![]() |
T. H. Ji, M. Grossmann, and I. Ji G Protein-coupled Receptors. I. DIVERSITY OF RECEPTOR-LIGAND INTERACTIONS J. Biol. Chem., July 10, 1998; 273(28): 17299 - 17302. [Full Text] [PDF] |
||||
![]() |
M. Beinborn, S. M. Quinn, and A. S. Kopin Minor Modifications of a Cholecystokinin-B/Gastrin Receptor Non-peptide Antagonist Confer a Broad Spectrum of Functional Properties J. Biol. Chem., June 5, 1998; 273(23): 14146 - 14151. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Waldhoer, E. Bofill-Cardona, G. Milligan, M. Freissmuth, and C. Nanoff Differential Uncoupling of A1 Adenosine and D2 Dopamine Receptors by Suramin and Didemethylated Suramin (NF037) Mol. Pharmacol., May 1, 1998; 53(5): 808 - 818. [Abstract] [Full Text] |
||||
![]() |
P. Wonerow, T. Schoneberg, G. Schultz, T. Gudermann, and R. Paschke Deletions in the Third Intracellular Loop of the Thyrotropin Receptor. A NEW MECHANISM FOR CONSTITUTIVE ACTIVATION J. Biol. Chem., April 3, 1998; 273(14): 7900 - 7905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonacchera, L. Chiovato, A. Pinchera, P. Agretti, E. Fiore, F. Cetani, R. Rocchi, P. Viacava, P. Miccoli, and P. Vitti Hyperfunctioning Thyroid Nodules in Toxic Multinodular Goiter Share Activating Thyrotropin Receptor Mutations with Solitary Toxic Adenoma J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 492 - 498. [Abstract] [Full Text] |
||||
![]() |
R. Paschke and M. Ludgate The Thyrotropin Receptor in Thyroid Diseases N. Engl. J. Med., December 4, 1997; 337(23): 1675 - 1681. [Full Text] [PDF] |
||||
![]() |
M. Simoni, J. Gromoll, and E. Nieschlag The Follicle-Stimulating Hormone Receptor: Biochemistry, Molecular Biology, Physiology, and Pathophysiology Endocr. Rev., December 1, 1997; 18(6): 739 - 773. [Abstract] [Full Text] |
||||
![]() |
H.-P. Holzapfel, D. Fuhrer, P. Wonerow, G. Weinland, W. A. Scherbaum, and R. Paschke Identification of Constitutively Activating Somatic Thyrotropin Receptor Mutations in a Subset of Toxic Multinodular Goiters J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4229 - 4233. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fuhrer, P. Wonerow, H. Willgerodt, and R. Paschke Identification of a New Thyrotropin Receptor Germline Mutation (Leu629Phe) in a Family with Neonatal Onset of Autosomal Dominant Nonautoimmune Hyperthyroidism J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4234 - 4238. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-P. Holzapfel, P. Wonerow, W. von Petrykowski, M. Henschen, W. A. Scherbaum, and R. Paschke Sporadic Congenital Hyperthyroidism due to a Spontaneous Germline Mutation in the Thyrotropin Receptor Gene J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3879 - 3884. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fuhrer, H.-P. Holzapfel, P. Wonerow, W. A. Scherbaum, and R. Paschke Somatic Mutations in the Thyrotropin Receptor Gene and Not in the Gs{alpha} Protein Gene in 31 Toxic Thyroid Nodules J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3885 - 3891. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Conchon, M.-B. Barrault, S. Miserey, P. Corvol, and E. Clauser The C-terminal Third Intracellular Loop of the Rat AT1A Angiotensin Receptor Plays a Key Role in G Protein Coupling Specificity and Transduction of the Mitogenic Signal J. Biol. Chem., October 10, 1997; 272(41): 25566 - 25572. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Parma, L. Duprez, J. Van Sande, J. Hermans, P. Rocmans, G. Van Vliet, S. Costagliola, P. Rodien, J. E. Dumont, and G. Vassart Diversity and Prevalence of Somatic Mutations in the Thyrotropin Receptor and Gs{alpha} Genes as a Cause of Toxic Thyroid Adenomas J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2695 - 2701. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Clifton-Bligh, J. W. Gregory, M. Ludgate, R. John, L. Persani, C. Asteria, P. Beck-Peccoz, and V. K. K. Chatterjee Two Novel Mutations in the Thyrotropin (TSH) Receptor Gene in a Child with Resistance to TSH J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1094 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Esapa, S. Foster, S. Johnson, J. L. Jameson, P. Kendall-Taylor, and P. E. Harris G Protein and Thyrotropin Receptor Mutations in Thyroid Neoplasia J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 493 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Govaerts, A. Lefort, S. Costagliola, S. J. Wodak, J. A. Ballesteros, J. Van Sande, L. Pardo, and G. Vassart A Conserved Asn in Transmembrane Helix 7 Is an On/Off Switch in the Activation of the Thyrotropin Receptor J. Biol. Chem., June 15, 2001; 276(25): 22991 - 22999. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Palanche, B. Ilien, S. Zoffmann, M.-P. Reck, B. Bucher, S. J. Edelstein, and J.-L. Galzi The Neurokinin A Receptor Activates Calcium and cAMP Responses through Distinct Conformational States J. Biol. Chem., September 7, 2001; 276(37): 34853 - 34861. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |